Med. praxi 2013; 10(11-12): 388-392

Clinical recomendations of community - acquired pneumonia diagnosis and treatment

MUDr.Petr Jakubec, prof.MUDr.Vítězslav Kolek, DrSc.
Klinika plicních nemocí a tuberkulózy FN a LF UP Olomouc

Community-acquired pneumonia is common and potentially serious illness with considerable morbidity and mortality, particularly in

elderly patients and significant comorbidities. It is the third most frequent cause of death in the world and leads to 3–5 milions of death

per year. Diagnosis of pneumonia is based on history, physical examination and finding of new infiltrate on chest radiograph, but many

other diagnostic examinations are performed as well. The cornerstone of pneumonia management is antibiotic therapy, but a lot of

other therapeutic procedures is necessary to use in the case of severe pneumonia.

Keywords: community-acquired pneumonia, diagnostics, management

Published: December 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jakubec P, Kolek V. Clinical recomendations of community - acquired pneumonia diagnosis and treatment. Med. praxi. 2013;10(11-12):388-392.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Brar, NK, Niederman, MS. Man Management of community-acquired pneumonia: a review and update. Ther Adv Respir Dis. 2011; 5: 61-78. Go to original source... Go to PubMed...
    2. Karhu J, Ala-Kokko TI, Ohtonen P, et al. Severe community-acquired pneumonia treated with beta-lactam-respiratory quinolone vs. beta-lactam-macrolide combination. Acta Anaesthesiol. Scand. 2013; 57: 587-593. Go to original source... Go to PubMed...
    3. Ewig S, Woodhead M, Torres A. Towards a sensible comprehension of severe community-acquired pneumonia. Intensive Care Med. 2011; 37: 214-223. Go to original source... Go to PubMed...
    4. Macfarlane JT, Boswell T, Douglas G, et al. BTS guidelines for the management of community acquired pneumonia in adults. Thorax. 2001; 56: 1-64. Go to original source...
    5. Bauer TT, Ewig S, Marre R, et al. CRB-65 predicts death from community-acquired pneumonia. J Intern Med. 2006; 260(1): 93-101. Go to original source... Go to PubMed...
    6. Mandell, LA, Wunderink, RG, Anzueto, A. et al. IDSA/ATS Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin.Infect.Dis. 2007, 44: 27-72. Go to original source... Go to PubMed...
    7. Lim, WS, Baudouin, SV, George, RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax, 2009, 64(III): iii1-iii55. Go to original source... Go to PubMed...
    8. Cillóniz C, Ewig S, Ferrer M, et al. Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis. Critical Care. 2011; 15(5): R209. doi: 10.1186/cc10444. Go to original source... Go to PubMed...
    9. Cilloniz C, Ewig S, Polverino E, et al. Community-acquired pneumonia in outpatients: etiology and outcomes. Eur Respir J. 2010; 40: 931-938. Go to original source... Go to PubMed...
    10. Kolek V, Kolář M, Kašák V, et al. Diagnostika a léčba komunitní pneumonie dospělých. In: Kolek, V. et al. Doporučené postupy v pneumologii. Maxdorf, Praha, 2013, 107-123.
    11. Gilbert DN, Spellberg B, Bartlett JG. Recommendations for diagnostic studies in respiratory tract infections. Clin Infect Dis. 2010; 51(1): 150-170. Go to original source...
    12. De Pascale G, Bello G, Tumbarello M, et al. Severe Pneumonia in Intensive Care. Cause, Diagnosis, Treatment and Management: A Review of the literature. Curr Opin Pulm Med. 2012; 18(3): 213-221. Go to original source... Go to PubMed...
    13. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections-Summary. Clin Microbiol Infect. 2011; 17(6): 1-24. Go to original source... Go to PubMed...
    14. Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. Am.J.Respir.Crit.Care Med. 2005; 171: 388-416. Go to original source... Go to PubMed...
    15. Koleff MH, Shorr A, Tabak YP, et al. Epidemiology and Outcomes of Health-care-Associated Pneumonia. Chest. 2005; 128: 3854-3862. Go to original source... Go to PubMed...
    16. Puskarich MA, Trzeciak S, Shapiro NI, et al. (EMSHOCKNET). Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med. 2011; 39: 2066-2071. Go to original source... Go to PubMed...
    17. Koleff, MH, Morrow, LE, Niederman, MS, et al. Clinical Characteristics and Treatment Patterns Among Patients With Ventilator-Associated Pneumonia. Chest. 2006; 129: 1210-1218. Go to original source... Go to PubMed...
    18. Ferrer M, Cosentini R, Nava S. The use of non-invasive ventilation during acute respiratory failure due to pneumonia. Eur J Inter Med. 2012; 23: 420-428. Go to original source... Go to PubMed...
    19. Corrales-Medina VF, Musher DM, Shachkina S, Chirinos JA. Acute pneumonia and the cardiovascular system. Lancet 2013; 381(9865): 496-505. doi: 10.1016/S0140-6736(12)61266-5. Go to original source... Go to PubMed...
    20. Peyrani P, Ramirez J. What is the association of cardiovascular events with clinical failure in patients with community-acquired pneumonia? Infect Dis Clin North Am 2013; 27: 205-210. Go to original source... Go to PubMed...
    21. Viasus D, Garcia-Vidal C, Manresa F, et al. Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia. J Infect 2013; 66(1): 27-31. Go to original source... Go to PubMed...
    22. Ott S, Hauptmeier B, Ernen C, et al. Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis. Eur Respir J. 2012; 39: 611-618. Go to original source... Go to PubMed...
    23. Menendez R, Cavalcanti M, Reyes S, et al. Markers of treatment failure in hospitalised community acquired pneumonia. Thorax. 2008; 63: 447-452. Go to original source... Go to PubMed...
    24. Goncalves-Pereira J, Conceicao C, Póvoa P. Community-acquired pneumonia: identification and evaluation of nonresponders. Ther Adv Infect Dis. 2013; 1(1): 5-17. Go to original source... Go to PubMed...
    25. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996; 275(2): 134-41. Go to original source... Go to PubMed...
    26. Sligl WI, Eurich DT, Marrie TJ. Only severely limited, premorbid functional status is associated with short-and long-term mortality in patients with pneumonia who are critically ill: a prospective observational study. Chest. 2011 Jan;139(1): 88-94. doi: 10.1378/chest.10-1054. Go to original source... Go to PubMed...
    27. Lindenauer PK, Lagu T, Shieh MS, et al. Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009. JAMA. 2012; 307(13):1405-13. doi: 10.1001/jama.2012.384. Go to original source... Go to PubMed...
    28. Nair GB, Niederman MS. Community-acquired pneumonia: an unfinished battle. Med Clin North Am. 2011; 95(6): 1143-61. doi: 10.1016/j.mcna.2011.08.007. Go to original source... Go to PubMed...
    29. Karhu J, Ala-Kokko TI, Ylipalosaari P, Ohtonen P, Laurila JJ, Syrjälä H. Hospital and long-term outcomes of ICU-treated severe community-and hospital-acquired, and ventilator-associated pneumonia patients. Acta Anaesthesiol Scand. 2011; 55(10): 1254-60. doi: 10.1111/j.1399-6576.2011.02535.x. Go to original source... Go to PubMed...
    30. Wheeler, AP, Bernard, GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007; 369: 1553-1564. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.